Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome

BACKGROUND: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome. METHODS: In total 74 adult ISM...

Descripción completa

Detalles Bibliográficos
Autores principales: Matito, Almudena, Morgado, José Mario, Álvarez-Twose, Iván, Laura Sánchez-Muñoz, Pedreira, Carlos Eduardo, Jara-Acevedo, María, Teodosio, Cristina, Sánchez-López, Paula, Fernández-Núñez, Elisa, Moreno-Borque, Ricardo, García-Montero, Andrés, Orfao, Alberto, Escribano, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796517/
https://www.ncbi.nlm.nih.gov/pubmed/24155887
http://dx.doi.org/10.1371/journal.pone.0076116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796517/
https://www.ncbi.nlm.nih.gov/pubmed/24155887
http://dx.doi.org/10.1371/journal.pone.0076116

Ejemplares similares